These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27918947)

  • 21. Endocervical and high vaginal quantitative fetal fibronectin in predicting preterm birth.
    Kuhrt K; Unwin C; Hezelgrave N; Seed P; Shennan A
    J Matern Fetal Neonatal Med; 2014 Oct; 27(15):1576-9. PubMed ID: 24294948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
    Bruijn MM; Kamphuis EI; Hoesli IM; Martinez de Tejada B; Loccufier AR; Kühnert M; Helmer H; Franz M; Porath MM; Oudijk MA; Jacquemyn Y; Schulzke SM; Vetter G; Hoste G; Vis JY; Kok M; Mol BW; van Baaren GJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
    Ng VWY; Seto MTY; Lewis H; Cheung KW
    BMC Pregnancy Childbirth; 2023 Apr; 23(1):225. PubMed ID: 37016314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting spontaneous preterm birth in asymptomatic high-risk women with cervical cerclage.
    Ridout AE; Ross G; Seed PT; Hezelgrave NL; Tribe RM; Shennan AH
    Ultrasound Obstet Gynecol; 2023 May; 61(5):617-623. PubMed ID: 36647576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study.
    Stock SJ; Horne M; Bruijn M; White H; Heggie R; Wotherspoon L; Boyd K; Aucott L; Morris RK; Dorling J; Jackson L; Chandiramani M; David A; Khalil A; Shennan A; Baaren GV; Hodgetts-Morton V; Lavender T; Schuit E; Harper-Clarke S; Mol B; Riley RD; Norman J; Norrie J
    Health Technol Assess; 2021 Sep; 25(52):1-168. PubMed ID: 34498576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of quantitative fetal fibronectin in predicting spontaneous preterm birth in symptomatic women: A retrospective cohort study.
    Nguyen AD; Liu CZ; Lehner C; Amoako AA; Sekar R
    Aust N Z J Obstet Gynaecol; 2019 Oct; 59(5):656-661. PubMed ID: 30724331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative Fetal Fibronectin at 18 Weeks of Gestation to Predict Preterm Birth in Asymptomatic High-Risk Women.
    Hezelgrave NL; Abbott DS; Radford SK; Seed PT; Girling JC; Filmer J; Tribe RM; Shennan AH
    Obstet Gynecol; 2016 Feb; 127(2):255-63. PubMed ID: 26942351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM; Sener T; Yildiz Z
    Clin Exp Obstet Gynecol; 2008; 35(1):61-4. PubMed ID: 18390084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Goldenberg RL; Iams JD; Das A; Mercer BM; Meis PJ; Moawad AH; Miodovnik M; VanDorsten JP; Caritis SN; Thurnau GR; Dombrowski MP; Roberts JM; McNellis D
    Am J Obstet Gynecol; 2000 Mar; 182(3):636-43. PubMed ID: 10739521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of spontaneous preterm birth using fetal fibronectin in women with a low-lying placenta.
    van der Krogt L; Hezelgrave NL; Seed PT; Shennan AH
    J Matern Fetal Neonatal Med; 2017 Feb; 30(3):313-316. PubMed ID: 27019973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a tool incorporating quantitative fetal fibronectin to predict spontaneous preterm birth in symptomatic women.
    Kuhrt K; Hezelgrave N; Foster C; Seed PT; Shennan AH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):210-6. PubMed ID: 25964191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Goepfert AR; Goldenberg RL; Mercer B; Iams J; Meis P; Moawad A; Thom E; VanDorsten JP; Caritis SN; Thurnau G; Miodovnik M; Dombrowski M; Roberts JM; McNellis D
    Am J Obstet Gynecol; 2000 Dec; 183(6):1480-3. PubMed ID: 11120514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical fetal fibronectin in patients at increased risk for preterm delivery.
    Bittar RE; Yamasaki AA; Sasaki S; Zugaib M
    Am J Obstet Gynecol; 1996 Jul; 175(1):178-81. PubMed ID: 8694047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the ability of cervical length and fetal fibronectin measurement to predict preterm delivery in asymptomatic women with risk factors.
    Zhou MX; Zhou J; Bao Y; Chen YQ; Cai C
    J Matern Fetal Neonatal Med; 2015 Jan; 28(2):153-7. PubMed ID: 24678648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin.
    Liong S; Di Quinzio MK; Fleming G; Permezel M; Rice GE; Georgiou HM
    BJOG; 2015 Feb; 122(3):370-9. PubMed ID: 25056135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour.
    Audibert F; Fortin S; Delvin E; Djemli A; Brunet S; Dubé J; Fraser WD
    J Obstet Gynaecol Can; 2010 Apr; 32(4):307-12. PubMed ID: 20500936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Application of Quantitative Foetal Fibronectin for the Prediction of Preterm Birth in Symptomatic Women.
    Radford SK; Da Silva Costa F; Araujo Júnior E; Sheehan PM
    Gynecol Obstet Invest; 2018; 83(3):285-289. PubMed ID: 29183020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.